Beet Kvass

Traditional Eastern European lacto-fermented beet tonic — combining the nitric oxide and betalain benefits of beets with live lactic acid bacteria for gut, blood pressure, and detoxification support

Beet kvass is a salty, earthy, deeply colored tonic made by lacto-fermenting raw beets in salt water for several days. The drink is a staple of Eastern European folk medicine, traditionally taken by the shot before meals to support digestion, the liver, and blood quality. Modern research backs up the intuition behind the tradition: the fermentation produces live lactic acid bacteria and concentrates beetroot's nitrates, betalains, and phenolic compounds — the same compounds linked to lower blood pressure [1][3], antioxidant defense, and gentle detoxification support [2].

What Beet Kvass Is

Kvass is a family of traditional fermented drinks from Russia, Ukraine, and the Baltic states. Bread kvass, made from stale rye, is the most familiar version. Beet kvass — sometimes called буряковий квас or kvas iz svekly — uses chopped raw beets, water, and sea salt instead. Wild lactic acid bacteria native to the beet skins ferment the natural sugars into lactic acid, dropping the pH and creating a sour, mineral-rich brine that keeps for weeks in the refrigerator.

A traditional ferment runs about 2–7 days at room temperature in a covered jar. The finished kvass is poured off, and a fresh batch can usually be made from the same beets a second time before they exhaust their sugars.

Why It's More Than Just Beet Juice

Beets are already nutritionally dense — they are one of the highest dietary sources of inorganic nitrate, which the body converts via oral and gut bacteria into nitric oxide, a vasodilator that relaxes blood vessels and lowers blood pressure [1][2]. They also contain betalains (the red pigments betanin and vulgaxanthin), which are potent antioxidants and Phase II detoxification enzyme inducers [2].

Lacto-fermentation adds a second layer:

Live bacteria — primarily Lactiplantibacillus plantarum, Lactobacillus brevis, and Lactiplantibacillus paracasei species — that survive the upper GI and reach the colon [4]
Bioactive metabolites — lactic acid, short-chain fatty acids, and bacterially modified phenolic compounds [6]
Improved bioavailability of nitrates, polyphenols, and minerals as the matrix breaks down
Lower sugar load than fresh beet juice, since the bacteria consume the natural sugars

The result is a drink that delivers many of the cardiovascular benefits of beetroot juice without the sugar spike, plus a probiotic and prebiotic component that fresh juice lacks.

How to Use It

Traditional intake is small: a shot glass (about 60 mL / 2 oz) once or twice daily, often before meals to stimulate stomach acid and bile flow. Larger doses can be loosening on the bowels, especially during the first week.

Look for raw, unpasteurized kvass in the refrigerated section of natural food stores, or make your own — the only ingredients are beets, sea salt, and water. Avoid commercial "beet kvass" that lists vinegar or has been heat-pasteurized; those products lose the live cultures even if some of the bioactive compounds remain.

People taking blood pressure medication, MAO inhibitors, or with a history of kidney stones (beets are high in oxalates) should start with very small amounts and check with a physician.

For more on the broader category, see our fermented foods overview and the sauerkraut page for the closest western analogue. The cardiovascular nitrate story is covered in more depth on the beets page.

Evidence Review

Direct human trials of beet kvass specifically are essentially nonexistent — almost all of the research has been done on either non-fermented beetroot juice or on lacto-fermented beetroot juice in animal models. Drawing conclusions about kvass requires combining these two literatures, which is reasonable because the kvass brine is essentially a lacto-fermented beet juice, but it should be done with care.

Blood Pressure and Cardiovascular Effects

The cardiovascular case for beets is one of the strongest in functional-food literature. Webb et al. (PMID 18250365), in a 2008 Hypertension paper, gave 14 healthy volunteers a single 500 mL dose of beetroot juice (containing approximately 22 mmol nitrate) and measured a 10.4 ± 3.0 mmHg drop in systolic blood pressure peaking around 2.5 hours, with effects detectable up to 24 hours. The mechanism was confirmed to be the entero-salivary nitrate-nitrite-NO pathway: when participants spat out their saliva for three hours after drinking the juice (preventing oral bacterial reduction of nitrate), neither plasma nitrite nor blood pressure changed, and platelet aggregation was unaffected.

A 2013 systematic review and meta-analysis by Siervo et al. (PMID 23596162) pooled 16 trials (254 participants) of inorganic nitrate or beetroot juice supplementation. The overall effect was a significant reduction of −4.4 mmHg systolic and −1.1 mmHg diastolic blood pressure, with larger effects after beetroot juice than after equivalent inorganic nitrate doses — suggesting that other compounds in the beet matrix (betalains, polyphenols) contribute beyond the nitrate alone.

Clifford et al.'s 2015 review in Nutrients (PMID 25875121) synthesized the evidence across blood pressure, endothelial function, exercise tolerance, and cognition, concluding that the betalain pigments contribute meaningfully to beetroot's antioxidant and anti-inflammatory effects independent of the nitrate-NO pathway. Whether kvass-level nitrate doses (much lower than the 500 mL pharmacological doses used in trials) produce clinically meaningful blood pressure changes is unknown, but smaller and more frequent intake is at least mechanistically plausible.

Gut Microbiota and Antioxidant Status

The closest direct evidence for beet kvass comes from a series of Polish studies on lactofermented beetroot juice (the Klewicka group). In a 2015 Nutrients paper (PMID 26193312), Klewicka and colleagues fed rats a diet supplemented with lactofermented beetroot juice for 28 days, with or without the carcinogen N-nitroso-N-methylurea. Supplementation modulated cecal microbiota composition, reduced fecal ammonia by 17%, and — when combined with the carcinogen — increased the antioxidant capacity of the blood serum aqueous fraction by approximately 69% compared with carcinogen alone. This suggests the fermented juice can both alter gut microbial activity and bolster systemic antioxidant defense in the face of an oxidative challenge.

An earlier Klewicka study (PMID 21185162, Experimental and Toxicologic Pathology, 2012) tested beetroot juice fermented by Lactobacillus brevis 0944 and Lactobacillus paracasei 0920 against carcinogen-induced aberrant crypt foci (ACF), an early precancerous marker, in rat colons. Fermented beetroot juice significantly reduced ACF count and the genotoxicity of fecal water compared with unfermented juice, indicating the lacto-fermented form had stronger chemoprotective activity than the same beets without fermentation.

Organic vs Conventional Fermentation

Kazimierczak et al. (PMID 24798659), in a 2014 Journal of the Science of Food and Agriculture paper, compared metabolomic profiles, antioxidant levels, and in vitro anticancer activity of naturally fermented beetroot juices from organic versus conventional production. Both fermented juices showed measurable anticancer activity against tumor cell lines, but the organic fermented juice was significantly more potent. This study is one of the few to actually characterize the bioactive profile of a kvass-style product and is a useful argument for sourcing organic beets when making kvass at home.

Limitations and Strength of Evidence

The evidence for beet kvass specifically is mostly indirect. Direct animal data is encouraging but limited to a handful of papers from a single research group, and human trials of fermented beetroot juice in particular are scarce. The blood pressure evidence is strong for beetroot juice at pharmacological doses (250–500 mL), but the smaller traditional kvass dose (around 60 mL) has not been studied at the same depth.

That said, the mechanistic picture is coherent: nitrates deliver vasodilation, betalains and polyphenols deliver antioxidant and Phase II detox support, and the lactic acid fermentation adds live microbes plus better bioavailability of these compounds. Beet kvass is a low-risk, low-cost, traditional preparation backed by strong mechanistic plausibility and encouraging — if indirect — clinical and preclinical data.

References

Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitriteWebb AJ, Patel N, Loukogeorgakis S, et al.. Hypertension, 2008. PubMed 18250365 →
The potential benefits of red beetroot supplementation in health and diseaseClifford T, Howatson G, West DJ, Stevenson EJ. Nutrients, 2015. PubMed 25875121 →
Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysisSiervo M, Lara J, Ogbonmwan I, Mathers JC. The Journal of Nutrition, 2013. PubMed 23596162 →
Effects of Lactofermented Beetroot Juice Alone or with N-nitroso-N-methylurea on Selected Metabolic Parameters, Composition of the Microbiota Adhering to the Gut Epithelium and Antioxidant Status of RatsKlewicka E, Nowak A, Zduńczyk Z, Cukrowska B, Błasiak J. Nutrients, 2015. PubMed 26193312 →
Protective effect of lactofermented beetroot juice against aberrant crypt foci formation and genotoxicity of fecal water in ratsKlewicka E, Zduńczyk Z, Juśkiewicz J, Klewicki R. Experimental and Toxicologic Pathology, 2012. PubMed 21185162 →
Beetroot (Beta vulgaris L.) and naturally fermented beetroot juices from organic and conventional production: metabolomics, antioxidant levels and anticancer activityKazimierczak R, Hallmann E, Lipowski J, et al.. Journal of the Science of Food and Agriculture, 2014. PubMed 24798659 →